Mangalam Drugs & Organics submits copy of revise financial results

19 Jul 2013 Evaluate

Mangalam Drugs & Organics has submitted a copy of revise Financial Results for the quarter and year ended March 31, 2013. The heading of the first column change from 'Unaudited - 3 months ended - March 31, 2013' to 'Audited - 3 months ended - March 31, 2013 - refer note no. 2'. There is no change in any of the financial figures submitted earlier.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

42.31 -2.22 (-4.99%)
27-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.05
Dr. Reddys Lab 1236.15
Cipla 1313.20
Zydus Lifesciences 895.85
Lupin 2142.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×